IRASEMA GONZALEZ: Open Payments
NPI 1013671882 · HUNTINGTON PARK, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$227 in 8 payments from 7 companies in 2025. Trend: 2023 $1,266 · 2024 $706 · 2025 $227
Food & beverage: $227
| Company | Payments | Amount |
|---|---|---|
| UCB, Inc. | 2 | $59 |
| GENZYME CORPORATION | 1 | $42 |
| ABBVIE INC. | 1 | $30 |
| Janssen Biotech, Inc. | 1 | $27 |
| Regeneron Healthcare Solutions, Inc. | 1 | $26 |
| Amgen Inc. | 1 | $23 |
| Arcutis Biotherapeutics, Inc. | 1 | $19 |
Products named: DUPIXENT, Bimzelx, RINVOQ, TREMFYA, OTEZLA, Zoryve.
Industry payments across CA — which companies pay providers there.
